medigraphic.com

2015, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (3)

The role of alexithymia as a psychosomatic factor in psoriasis

Torres-Hernández M, López-García S, Pedroza-Escobar D, Escamilla-Tilch M

Language: Spanish
References: 28
Page: 268-272
PDF size: 91.18 Kb.


ABSTRACT

Background: Alexithymia is the lack of mental representations of emotions leading to limited ability to understand and regulate these and can contribute to the development or maintenance of a psychosomatic illness. The aim of the study was to demonstrate that alexithymia is a feature that occurs more frequently in patients with psoriasis and that the coexistence of alexitimia-psoriasis is associated with high levels of trait anxiety.
Methods: We applied the Toronto Alexithymia Scale -20 (TAS-20), Inventory of state-trait anxiety (STAI) to 16 outpatients with psoriasis of Dermatology Service of Hospital de Especialidades (Centro Médico Nacional Siglo XXI) and the results were compared with 25 control subjects.
Results: 25 % of patients with psoriasis presented alexitimia, while in the control group was 8 % (p = 0.002). Correlation between the scores of the TSA-20 and STAI-trait (r = 0.6957, p ‹ 0.0001) was observed.
Conclusions: The alexitimia occurs more frequently in individuals with psoriasis than in the general population, and levels of trait anxiety in individuals with psoriasis are similar regardless of the presence of alexithymia.


REFERENCES

  1. Heinrich TW. Medically unexplained symptoms and the concept of somatization. WMJ. 2004;103(6):83-7.

  2. Dragos D, Tanasescu MD. The critical role of psychosomatics in promoting a new perspective upon health and disease. J Med Life, 2009;2(4):343-9.

  3. Woolfolk RL, Allen LA, Tiu JE. New directions in the treatment of somatization. Psychiatr Clin North Am. 2007;30(4):621-44.

  4. Smith GR, Monson RA, Ray DC. Patients with mul tiple unexplained symptoms. Their characteristics, functional health, and health care utilization. Ar ch Intern Med, 1986; 146(1):69-72.

  5. Mattila AK, Kronholm E, Jula A, Salminen JK, Koivisto AM, Mielonen RL et al. Alexithymia and somatization in general population. Psychosom Med. 2008;70(6):716-22.

  6. De Gucht V, Heiser W. Alexithymia and somatisation: quantitative review of the literature. J Psychosom Res, 2003;54(5):425-34.

  7. Lumley MA, Neely LC, Burger AJ. The assessment of alexithymia in medical settings: implications for understanding and treating health problems. J Pers Assess, 2007; 89(3):230-46.

  8. Kano M, Fukudo S. The alexithymic brain: the neural pathways linking alexithymia to physical disorders. Biopsychosoc Med. 2013;7(1):1.

  9. Bailey PE, Henry JD. Alexithymia, somatization and negative affect in a community sample. Psychiatry Res. 2007;150(1):13-20.

  10. Kojima M. Alexithymia as a prognostic risk factor for health problems: a brief review of epidemiological studies. Biopsychosoc Med. 2012;6(1):21.

  11. Willemsen RD, Roseeuw D, Vanderlinden J. Alexithymia and dermatology: the state of the art. Int J Dermatol, 2008; 47(9):903-10.

  12. Bahmer JA, Kuhl J, Bahmer FA. How do personality systems interact in patients with psoriasis, atopic dermatitis and urticaria? Acta Derm Venereol. 2007;87(4):317-24.

  13. Manolache LD, Petrescu-Seceleanu D, Benea V. Life events involvement in psoriasis onset/ recurrence. Int J Dermatol. 2010;49(6):636-41.

  14. Chaudhury S, Das AL, John RT, Ramadasan P. Psychological factors in psoriasis. Indian J Psychiatry. 1998; 40(3):295-9. Texto libre http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2966606/

  15. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010; 146(8):891-5.

  16. Rieder E y Tausk F. Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol. 2011;51(1):12-26.

  17. Hayes J y Koo J. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther. 2010; 23(2):174-80.

  18. Parafi anowicz K, Sicinska J, Moran A, Szumanski J, Staniszewski K, Rudnicka L, et al. [Psychiatric comorbidities of psoriasis: pilot study]. Psychiatr Pol. 2010;44(1):119-26.

  19. Russo PA, Ilchef R, Cooper AJ, Psychiatric morbidity in psoriasis: a review. Australas J Dermatol. 2004; 45(3):155-9; quiz 160-1.

  20. Masmoudi J, Maalej I, Masmoudi A, Rached H, Rebai A, Turki H, et al. [Alexithymia and psoriasis: a case-control study of 53 patients]. Encephale, 2009;35(1):10-7.

  21. Picardi A, Mazzotti E, Gaetano P, Cattaruzza MS, Baliva G, Melchi CF, et al. Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics, 2005; 46(6): 556-64.

  22. Richards HL, Fortune DG, Griffi ths CE, Main CJ. Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. J Psychosom Res, 2005; 58(1):89-96.

  23. Hall JM, Cruser D, Podawiltz A, Mummert DI, Jones H, Mummert ME. Psychological stress and the cutaneous immune response: Roles of the HPA axis and the sympathetic nervous system in atopic dermatitis and psoriasis. Dermatol Res Pract.2012; 2012:403908. doi: 10.1155/2012/403908. Epub 2012 Aug 30. Disponible en http://www.hindawi.com/ journals/drp/2012/403908/

  24. Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Baliva G, Melchi CF, et al. Only limited support for a role of psychosomatic factors in psoriasis. Results from a case-control study. J Psychosom Res, 2003; 55(3):189-96.

  25. Golpour M, Hosseini SH, Khademloo M, Ghasemi M, Ebadi A, Koohkan F, et al. Depression and anxiety disorders among patients with psoriasis: A hospitalbased case-control study. Dermatol Res Pract.2012; 2012:381905. doi: 10.1155/2012/381905. Epub 2012 Jul 16. Texto libre http://www.hindawi.com/journals/ drp/2012/381905/

  26. Guilbaud O, Corcos M, Hjalmarsson L, Loas G, Jeammet P. Is there a psychoneuroimmunological pathway between alexithymia and immunity? Immune and physiological correlates of alexithymia. Biomed Pharmacother, 2003; 57(7): 292-5.

  27. Heller MM, Lee ES, Koo JY. Stress as an infl uencing factor in psoriasis. Skin Therapy Lett.2011;16(5):1-4. Texto libre http://www.skintherapyletter.com/2011/16 .5/1.html

  28. Taylor AG, Goehler LE, Galper DI, Innes KE, Bourguignon C. Top-down and bottom-up mechanisms in mind-body medicine: development of an integrative framework for psychophysiological research. Explore. 2010; 6(1): 29-41. Texto libre http://www.ncbi.nlm.nih. gov/pmc/articles/PMC2818254/




2020     |     www.medigraphic.com